Table 1.

Percentage of women with single HPV infections having any cytologic abnormalities

HPV typeTotal N% Abnormal (95% CI) *Abnormal N% ASC % LSIL% HSIL+
All single infections 1,22224.8 (22.4-27.3)30344.232.023.8
α1/α8/α105018.0 (8.6-31.4)955.644.40.0
    HPV62317.4 (5.0-38.8)425.075.00.0
    HPV11520.0 (0.5-71.6)1100.00.00.0
    HPV741100.010.0100.00.0
    HPV55425.0 (0.6-80.6)1100.00.00.0
    HPV40450.0 (6.8-93.2)2100.00.00.0
    HPV32100.00
    HPV4230.00
α132218.2 (5.2-40.3)4100.00.00.0
    HPV542218.2 (5.2-40.3)4100.00.00.0
α935133.9 (29.0-39.1) *11928.625.246.2
    HPV52 §3918.0 (7.5-33.5)742.942.914.3
    HPV67580.0 (28.4-99.5) *475.025.00.0
    HPV332330.4 (13.2-52.9)771.414.314.3
    HPV587032.9 (22.1-45.1)2330.434.834.8
    HPV1615638.5 (30.8-46.6) *6021.718.360.0
    HPV314626.1 (14.3-41.1)120.041.758.3
    HPV351250.0 (21.1-78.9) *650.016.733.3
α111145.5 (16.7-76.6)540.060.00.0
    HPV73 955.6 (21.2-86.3) *540.060.00.0
    HPV3410.00
    HPV6410.00
α721825.7 (20.0-32.0)5651.837.510.7
    HPV59944.4 (13.7-78.8)450.025.025.0
    HPV183930.8 (17.0-47.6)1258.325.016.7
    HPV451612.5 (1.6-38.3)2100.00.00.0
    HPV708522.4 (14.0-32.7)1963.236.80.0
    HPV393043.3 (25.5-62.6) *1323.169.27.7
    HPV681338.5 (13.9-68.4)560.020.020.0
    HPV85263.8 (0.1-19.6) *10.00.0100.0
α58431.0 (21.3-42.0)2653.926.919.2
    HPV26 520.0 (0.5-71.6)10.00.0100.0
    HPV517233.3 (22.7-45.4)2454.229.216.7
    HPV82 616.7 (0.4-64.1)1100.00.00.0
    HPV6910.00
α611930.3 (22.2-39.3)3636.155.68.3
    HPV537420.3 (11.8-31.2)1553.326.720.0
    HPV562748.1 (28.7-68.1) *1315.484.60.0
    HPV661844.4 (21.5-69.2)837.562.50.0
α1511813.6 (8.0-21.1) *1675.018.86.3
    HPV7111813.6 (8.0-21.1) *1675.018.86.3
α324912.9 (9.0-17.7) *3265.628.16.3
    HPV611015.0 (1.6-11.2) *560.020.020.0
    HPV721010.0 (0.3-44.5)1100.00.00.0
    HPV625416.7 (7.9-29.3)988.911.10.0
    HPV812623.1 (9.0-43.6)666.733.30.0
    HPV833813.2 (4.4-28.1)560.020.020.0
    HPV89425.0 (0.6-80.6)10.0100.00.0
    HPV841631.3 (11.0-58.7)540.060.00.0
α1/α8/α10/α137218.1 (10.0-28.9)1369.230.80.0
α9/α1136234.3 (29.4-39.4) *12429.026.644.4
α9/α11(HPV16-)20631.1 (24.8-37.9) *6435.934.429.7
α721825.7 (20.0-32.0)5651.837.510.7
α5/α620330.5 (24.3-37.4) *6243.643.612.9
α3/α1536713.1 (9.8-17.0) *4868.825.06.3
All carcinogenic57034.4 (30.5-38.4) *19633.733.732.7
Carcinogenic (HPV16−)41432.9 (28.3-37.6) *13639.040.420.6
Noncarcinogenic65216.4 (13.6-19.5) *10763.629.07.5
HPV negative5,9258.0 (7.4-8.8) *47686.110.92.9
  • Abbreviations: α, α species; N, frequency; ASC, atypical squamous cells of undetermined significance; HSIL+, high-grade squamous intraepithelial lesions or worse.

  • * Percentage of women with cytologic abnormalities (ASC or worse). Significant findings at the 95% confidence level relative to all other single HPV infections except the HPV type/group in question are indicated by an asterisk.

  • Of the women with abnormal cytologic interpretations, the percentage of women with ASC, LSIL, and HSIL or worse were reported.

  • Of the HPV type (single infections), HPV57 had no positive findings.

  • § Bold indicates the HPV type is one of the 14 HPV types we categorized as carcinogenic.

  • Categorized as a possibly carcinogenic HPV type.